Vendor, Marlborough, NH
Spring Mill Pharma Incorporated
UEI UWZNAK5HJLN7, CAGE 12P11
1 award and $0 obligated between July 23, 2026 and July 23, 2026, 100% under full and open competition, against 12.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93020C00016Definitive Contract, July 23, 2026, Full and Open Competition, 12 offers | National Institutes of Health NiaidNational Institutes of Health | EO14398 - Non Beta-Lactam Inhibitors of Penicillin Binding Proteins Targeting Mdr-Acinetobacter Baumannii.NAICS 541715, PSC AN12 | $0 |
- Places of performance
- Pennsylvania
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards